Omnia SanaPlant Comparison
Blue gum eucalyptus vs Eyebright
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Blue gum eucalyptus and Eyebright: they share 6 indicated uses (arthritis / joint pain, infection (general), inflammation (general), …); 1 pharmacological action in common.
Evidence face-off — shared uses
| Condition | Blue gum eucalyptus | Eyebright | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 2/10 | 1/10 | Comparable evidence |
| Infection (general) | 2/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 2/10 | 2/10 | Comparable evidence |
| Respiratory support | 2/10 | 1/10 | Comparable evidence |
| Skin irritation | 2/10 | 1/10 | Comparable evidence |
| Wounds | 2/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Leaf essential oil dominated by 1,8-cineole (eucalyptol, typically 70%+), the principal compound responsible for the plant's antimicrobial, anti-inflammatory and expectorant/decongestant activity.
Give the plant its anti-inflammatory action on irritated tissue.
Pharmacological Actions
Astringent and anti-inflammatory for eye irritation, redness and conjunctivitis (traditional, as an eye compress or bath) - an open prospective cohort of Euphrasia single-dose eye drops reported recovery or clear improvement in most patients with conjunctivitis
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from immunomodulator action
inferred from antifungal action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Eases eye strain and watery, itchy eyes from allergy (hay fever / allergic conjunctivitis)
inferred from anti-inflammatory action
inferred from anticancer action
Soothes upper-respiratory catarrh and mild infection (traditional)
Astringent and anti-inflammatory for eye irritation, redness and conjunctivitis (traditional, as an eye compress or bath) - an open prospective cohort of Euphrasia single-dose eye drops reported recovery or clear improvement in most patients with conjunctivitis; Eases eye strain and watery, itchy eyes from allergy (hay fever / allergic conjunctivitis)
Eases eye strain and watery, itchy eyes from allergy (hay fever / allergic conjunctivitis)
Soothes upper-respiratory catarrh and mild infection (traditional)
inferred from anti-inflammatory action
Soothes upper-respiratory catarrh and mild infection (traditional)
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Eucalyptus globulus essential oil is highly concentrated and rich in the monoterpene 1,8-cineole; it should never be applied undiluted to the skin or ingested outside of standardized pharmaceutical preparations. Improper use can cause irritation, nausea, dizziness, or neurological symptoms, and inhalation at high concentrations may provoke respiratory distress, particularly in infants, young children, or individuals with asthma or other airway sensitivities. For this reason, essential oil use is generally discouraged in children and during pregnancy unless under professional guidance. Preparations such as leaf-infused oils or external applications using whole plant material are considerably milder, but they should still be used with care and an understanding that different preparation methods carry different levels of risk.
Duke (2002) provides clinical evidence (score 2) for eucalyptus as an expectorant and topical hyperemic (rubefacient), consistent with Commission E approval. Clinical evidence also supports its use in asthma, bronchitis, and catarrh. The essential oil (primarily 1,8-cineole) is the active constituent. Therapeutic use as steam inhalation is well-established. Internal use of the essential oil at high doses is contraindicated due to toxicity; even small amounts (3.5 ml) can be fatal in children. Contraindicated for inflammatory diseases of the gastrointestinal tract or bile ducts (Duke, 2002).
CRITICAL: do not put non-sterile, homemade eyebright preparations directly into the eye - this risks serious eye infection. Use only commercially prepared sterile products in the eye, or apply a strained, cooled infusion as a compress over closed eyelids.
Traditional use only; persistent eye symptoms, pain, discharge or vision change need assessment by an eye-care professional. Safety in pregnancy and breastfeeding is not established.
External Ids
Botanical Description
Large, fast-growing evergreen tree with distinctive two-stage leaves: rounded, silvery-blue juvenile leaves borne in opposite pairs, giving way to narrow, sickle-shaped, aromatic, dark green mature leaves as the tree ages. Small, cream-white, fluffy flowers with numerous stamens are borne singly or in small clusters, followed by a woody, cup-shaped seed capsule ('gum nut').[12]
Small, semi-parasitic annual herb (drawing some nutrients from the roots of neighbouring grasses) with tiny, opposite, toothed leaves and delicate, two-lipped white to pale lilac flowers marked with purple veins and a yellow throat spot, giving a bright, eye-like appearance that inspired both its common and Latin names.[11]
Habitat
Native to south-eastern Australia and Tasmania; widely planted worldwide in warm-temperate and Mediterranean climates for timber, essential oil production and as an ornamental/windbreak tree.
Grows in short, unimproved grassland, pastures, meadows and dunes on well-drained soils, always in association with grasses on which it partially parasitises; native to Europe.[11]
Harvesting
Mature leaves are picked or pruned year-round and used fresh, dried, or steam-distilled for essential oil, which is the main commercial and medicinal form.
The flowering aerial parts are cut in summer while in flower and dried in a warm, shaded, airy place.[11]
Traditional Uses
Eucalyptus leaf has a long Australian Aboriginal and, after global spread, worldwide tradition as a respiratory remedy - inhaled as steam or applied as chest rubs for colds, coughs, bronchitis and catarrh - and as a topical antiseptic and rubefacient for minor wounds and muscular aches.[12]
Preparations
A few drops of essential oil, or fresh/dried leaf, added to hot water and the vapour inhaled for respiratory congestion; the classic and best-established use.
Diluted essential oil in a carrier oil or standardised ointment applied to the chest and back for coughs and colds.
Comminuted dried leaf infused in 150 ml boiling water, 1.5-3 g up to four times daily (daily dose 4.5-12 g) for oral use per the EU herbal monograph. Educational reference only, not a prescription.
Strained, cooled infusion applied as a compress over closed eyelids, or used (only when sterile, commercially prepared) as an eyewash for irritated or red eyes.
Commercially prepared, sterile Euphrasia eye drops used for conjunctivitis; a prospective clinical cohort found improvement in most users.
Dosage
The EU herbal monograph on eucalyptus LEAF gives, for inhalation, 3 g of the comminuted leaf in boiling water up to 3 times daily (daily dose 3-9 g), and for oral use 1.5-3 g in 150 mL as an infusion up to 4 times daily (daily dose 4.5-12 g), in adolescents, adults and elderly. Use is CONTRAINDICATED in children under 30 months, and not recommended under 12 years. The essential oil is a separate herbal substance with its own monograph and its own posology - it is never taken internally or applied undiluted to skin on the strength of these leaf figures. Educational reference only, not a prescription.
No dose is given here because no official posology exists. The HMPC assessed eyebright and DECLINED to establish a herbal monograph, concluding that the efficacy of the claimed uses is undocumented and that external eye application of ex tempore (home-prepared) preparations is 'not hygienic and not safe', so therapeutic use cannot be recommended. Traditional sources describe a strained, cooled infusion used as a compress, but that is precisely the practice the HMPC advised against; nothing home-prepared should be put in or on the eye. Educational reference only, not a prescription.
References
Lookalikes Review
References & Sources
- Čmiková, N., Galovičová, L., Schwarzová, M., Vukic, M.D. et al (2023) 'Chemical Composition and Biological Activities of Eucalyptus globulus Essential Oil', Plants (Basel), 12(5), pp. 1076. doi:10.3390/plants12051076 Preclinical
https://doi.org/10.3390/plants12051076 - Elangovan, S. and Mudgil, P (2023) 'Antibacterial Properties of Eucalyptus globulus Essential Oil against MRSA: A Systematic Review', Antibiotics (Basel), 12(3), pp. 474. doi:10.3390/antibiotics12030474 Meta-analysis / review
https://doi.org/10.3390/antibiotics12030474 - Zonfrillo, M., Andreola, F., Krasnowska, E.K., Sferrazza, G. et al (2022) 'Essential Oil from Eucalyptus globulus (Labill.) Activates Complement Receptor-Mediated Phagocytosis and Stimulates Podosome Formation in Human Monocyte-Derived Macrophages', Molecules, 27(11), pp. 3488. doi:10.3390/molecules27113488 Preclinical
https://doi.org/10.3390/molecules27113488 - Arooj, B., Asghar, S., Saleem, M., Khalid, S.H., Asif, M., Chohan, T., Khan, I.U., Zubair, H.M. and Yaseen, H.S (2023) 'Anti-inflammatory mechanisms of eucalyptol rich Eucalyptus globulus essential oil alone and in combination with flurbiprofen', Inflammopharmacology, 31(4), pp. 1849-1862. doi:10.1007/s10787-023-01237-6 Preclinical
https://doi.org/10.1007/s10787-023-01237-6 - Assaggaf, H.M., Naceiri Mrabti, H., Rajab, B.S., Attar, A.A., Hamed, M., Sheikh, R.A., Omari, N.E., Menyiy, N.E., Belmehdi, O., Mahmud, S., Alshahrani, M.M., Park, M.N., Kim, B., Zengin, G. and Bouyahya, A (2022) 'Singular and Combined Effects of Essential Oil and Honey of Eucalyptus globulus on Anti-Inflammatory, Antioxidant, Dermatoprotective, and Antimicrobial Properties: In Vitro and In Vivo Findings', Molecules, 27(16), pp. 5121. doi:10.3390/molecules27165121 Preclinical
https://doi.org/10.3390/molecules27165121 - Mulyaningsih, S., Sporer, F., Zimmermann, S., Reichling, J. and Wink, M (2010) 'Synergistic properties of the terpenoids aromadendrene and 1,8-cineole from the essential oil of Eucalyptus globulus against antibiotic-susceptible and antibiotic-resistant pathogens', Phytomedicine, 17(13), pp. 1061-1066. doi:10.1016/j.phymed.2010.06.018 Preclinical
https://doi.org/10.1016/j.phymed.2010.06.018 - Luis, A., Neiva, D., Pereira, H., Gominho, J., Domingues, F. and Duarte, A.P (2014) 'Stumps of Eucalyptus globulus as a source of antioxidant and antimicrobial polyphenols', Molecules, 19(10), pp. 16428-16446. doi:10.3390/molecules191016428 Preclinical
https://doi.org/10.3390/molecules191016428 - Merghni, A., Noumi, E., Hadded, O., Dridi, N., Panwar, H., Ceylan, O., Mastouri, M. and Snoussi, M (2018) 'Assessment of the antibiofilm and antiquorum sensing activities of Eucalyptus globulus essential oil and its main component 1,8-cineole against methicillin-resistant Staphylococcus aureus strains', Microbial Pathogenesis, 118, pp. 74-80. doi:10.1016/j.micpath.2018.03.006 Preclinical
https://doi.org/10.1016/j.micpath.2018.03.006 - Mousa, A.A., Elweza, A.E., Elbaz, H.T., Tahoun, E.A.E., Shoghy, K.M., Elsayed, I. and Hassan, E.B (2019) 'Eucalyptus Globulus protects against diclofenac sodium induced hepatorenal and testicular toxicity in male rats', Journal of Traditional and Complementary Medicine, 10(6), pp. 521-528. doi:10.1016/j.jtcme.2019.11.002 Preclinical
https://doi.org/10.1016/j.jtcme.2019.11.002 - Mota, V.S., Turrini, R.N.T. and Poveda, V.B (2015) 'Antimicrobial activity of Eucalyptus globulus oil, xylitol and papain: a pilot study', Revista da Escola de Enfermagem da USP, 49(2), pp. 216-220. doi:10.1590/S0080-623420150000200005 Preclinical
https://doi.org/10.1590/S0080-623420150000200005 - Nguyen, H.T.T., Miyamoto, A., Nguyen, H.T., Pham, H.T., Hoang, H.T., Tong, N.T.M., Truong, L.T.N. and Nguyen, H.T.T (2023) 'Antibacterial effects of essential oils from Cinnamomum cassia bark and Eucalyptus globulus leaves - the involvements of major constituents', PLoS One, 18(7), pp. e0288787. doi:10.1371/journal.pone.0288787 Preclinical
https://doi.org/10.1371/journal.pone.0288787 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - European Medicines Agency (HMPC) (2013) 'Community herbal monograph on Eucalyptus globulus Labill., folium'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-eucalyptus-globulus-labill-folium_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-eucalyptus-globulus-labill-folium_en.pdf - Sadlon, A.E. and Lamson, D.W (2010) 'Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices', 15(1), pp. 33--47. Preclinical
https://scholar.google.com/scholar?q=Immune-modifying%20and%20antimicrobial%20effects%20of%20Eucalyptus%20oil%20and%20simple%20inhalation%20devices - World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Novy, P., Davidova, H., Serrano-Rojero, C.S., Rondevaldova, J. et al (2015) 'Composition and Antimicrobial Activity of Euphrasia rostkoviana Hayne Essential Oil', Evidence-Based Complementary and Alternative Medicine, 2015, pp. 734101. doi:10.1155/2015/734101 Preclinical
https://doi.org/10.1155/2015/734101 - D'Ambrosio, M., Ciocarlan, A. and Aricu, A (2020) 'Minor acetylated metabolites from Euphrasia rostkoviana', Natural Product Research, 34(2), pp. 290-295. doi:10.1080/14786419.2018.1530227 Preclinical
https://doi.org/10.1080/14786419.2018.1530227 - Ververis, A., Kyriakou, S., Paraskeva, H., Panayiotidis, M.I. et al (2024) 'Chemical Characterization and Assessment of the Neuroprotective Potential of Euphrasia officinalis', International Journal of Molecular Sciences, 25(23), pp. 12902. doi:10.3390/ijms252312902 Preclinical
https://doi.org/10.3390/ijms252312902 - Meier-Girard, D., Gerstenberg, G., Stoffel, L., Kohler, T., Klein, S.D., Eschenmoser, M., Mitter, V.R., Nelle, M. and Wolf, U (2020) 'Euphrasia eye drops in preterm neonates with ocular discharge: a randomized double-blind placebo-controlled trial', Frontiers in Pediatrics, 8, pp. 449. doi:10.3389/fped.2020.00449 Randomized trial
https://doi.org/10.3389/fped.2020.00449 - Liu, Y., Hwang, E., Ngo, H.T.T., Perumalsamy, H., Kim, Y.J., Li, L. and Yi, T.H (2018) 'Protective effects of Euphrasia officinalis extract against ultraviolet B-induced photoaging in normal human dermal fibroblasts', International Journal of Molecular Sciences, 19(11), pp. 3327. doi:10.3390/ijms19113327 Preclinical
https://doi.org/10.3390/ijms19113327 - Porchezhian, E., Ansari, S.H. and Shreedharan, N.K (2000) 'Antihyperglycemic activity of Euphrasia officinale leaves', Fitoterapia, 71(5), pp. 522-526. doi:10.1016/s0367-326x(00)00204-5 Preclinical
https://doi.org/10.1016/s0367-326x(00)00204-5 - Sticher, O. and Salama, O (1981) 'Iridoid glucosides from Euphrasia rostkoviana', Planta Medica, 42(6), pp. 122-123. doi:10.1055/s-2007-971584 Preclinical
https://doi.org/10.1055/s-2007-971584 - Lorenz, P., Knittel, D.N., Conrad, J., Lotter, E.M., Heilmann, J., Stintzing, F.C. and Kammerer, D.R (2016) '1-Acetyl-3-[(3R)-hydroxyfatty acyl]glycerols: lipid compounds from Euphrasia rostkoviana Hayne and E. tetraquetra (Breb.) Arrond', Chemistry & Biodiversity, 13(5), pp. 602-612. doi:10.1002/cbdv.201500233 Preclinical
https://doi.org/10.1002/cbdv.201500233 - Gawenda-Kempczynska, D., Olech, M., Balcerek, M., Nowak, R., Zaluski, T. and Zaluski, D (2022) 'Phenolic acids as chemotaxonomic markers able to differentiate the Euphrasia species', Phytochemistry, 203, pp. 113342. doi:10.1016/j.phytochem.2022.113342 Preclinical
https://doi.org/10.1016/j.phytochem.2022.113342 - Benedec, D., Oniga, I., Hanganu, D., Vlase, A.M., Ielciu, I., Crisan, G., Fit, N., Niculae, M., Bab, T., Pall, E. and Vlase, L (2024) 'Revealing the Phenolic Composition and the Antioxidant, Antimicrobial and Antiproliferative Activities of Two Euphrasia sp. Extracts', Plants, 13(13), pp. 1790. doi:10.3390/plants13131790 Preclinical
https://doi.org/10.3390/plants13131790 - Herbal Reality (n.d.) 'Eyebright (Euphrasia officinalis): Benefits, Uses, Safety'. Available at: https://www.herbalreality.com/herb/eyebright/ Traditional / reference
https://www.herbalreality.com/herb/eyebright/ - Paduch, R. and colleagues (2014) 'Assessment of Eyebright (Euphrasia officinalis L.) Extract Activity in Relation to Human Corneal Cells Using In Vitro Tests'. doi:10.5152/balkanmedj.2014.8377 Traditional / reference
https://doi.org/10.5152/balkanmedj.2014.8377 - Stoss, M., Michels, C., Peter, E., Beutke, R. and Gorter, R.W (2000) 'Prospective cohort trial of Euphrasia single-dose eye drops in conjunctivitis', Journal of Alternative and Complementary Medicine, 6(6), pp. 499--508. doi:10.1089/acm.2000.6.499 Clinical study
https://doi.org/10.1089/acm.2000.6.499 - European Medicines Agency (HMPC) (2010) 'Public statement on Euphrasia officinalis L. and Euphrasia rostkoviana Hayne, herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-report/final-public-statement-euphrasia-officinalis-l-and-euphrasia-rostkoviana-hayne-herba_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-report/final-public-statement-euphrasia-officinalis-l-and-euphrasia-rostkoviana-hayne-herba_en.pdf
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.